Large hospitals are actively experimenting with generative artificial intelligence technologies, which are viewed as capable of fundamentally transforming certain aspects of care services and saving costs. Healthcare institutions are racing to adopt generative AI, but regulatory agencies are struggling to keep pace with technological advancements, leading to challenges in risk and liability. The potential risks and unknowns posed by generative AI complicate regulatory efforts, placing regulators in a dilemma regarding the management of new technologies.